Does TVTX pay a dividend?

The cached stock data on this page does not show a positive dividend yield for TVTX. Dividend status can change, so verify the latest company filings before relying on income assumptions.

What does TVTX stock do?

Commercial rare disease biopharmaceutical company developing and commercializing targeted oral therapies for kidney and metabolic disorders.

What is TVTX stock's price target?

This cached page does not contain a precise model fair value for TVTX.

The TradeMates model verdict for TVTX is BUY with an investment score of 65/100. Treat this as a model signal to review, not a personal buy recommendation.

Is TVTX a good dividend stock?

TVTX is not presented as a dividend idea on this cached TradeMates page because no positive dividend yield is available in the cached data.

TVTX (TVTX) Stock Analysis

Q: Is TVTX stock a good investment?

The cached TradeMates AI model rates TVTX as BUY with an investment score of 65/100. The model score of 65/100 falls in the BUY range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.

Verdict: BUY

FILSPARI's rapid IgAN/FSGS commercial ramp drives profitability, but debt obligations and valuation near consensus cap near-term upside.

Investment score: 65/100

The model score of 65/100 falls in the BUY range. The central thesis and factor breakdown explain the assessment.

Peers

RYTM
CGON
MIRM
ORKA
SRRK

Peer	P/E	P/B	P/S	EV/EBITDA	ROIC %	Net margin %
RYTM	-32.28	31.69	28.70	-36.94	—	-0.86
CGON	-28.06	6.49	1072.79	-30.01	—	-36.03
MIRM	-6.80	-602.20	9.77	-8.33	—	-1.39
ORKA	-38.85	5.41	0.00	-38.98	—	0.00
SRRK	-14.82	25.24	0.00	-14.24	—	0.00

View the full interactive analysis